- ►pubget.com [PDF] G Férir, S Kaptein, J Neyts, E De Clercq - Reviews in Medical Virology, 2008 - ingentaconnect.com A decade ago, standard therapy against chronic hepatitis B virus infections only
consisted of lamivudine or IFN- . Treatment with lamivudine and IFN has been
compounded by, respectively, the emergence of drug-resistant virus strains ... Cited by 13 - Related articles - BL Direct - All 5 versions
GY Wu, HS Chen - WORLD JOURNAL OF GASTROENTEROLOGY, 2007 - wjg.wjgnet.com Abstract Currently approved treatments for hepatitis B virus (HBV) infection
include the immunomodulatory agent, IFN-α, and nucleos(t)ide analogues. Their
efficacy is limited by their side effects, as well as the induction of ... Cited by 11 - Related articles - Cached - BL Direct - All 6 versions
C Balsano, A Alisi - Current medicinal chemistry, 2008 - ingentaconnect.com 1 Laboratory of Molecular Virology and Oncology, Fondazione A. Cesalpino,
University of Rome "La Sapienza", Rome, Italy 2 Dept. of Internal Medicine,
University of L'Aquila, L'Aquila, Italy 3 Liver Unit, Bambino Gesù ... Cited by 7 - Related articles - BL Direct - All 3 versions
RG Gish, S Locarnini - Clinics in Liver Disease, 2007 - Elsevier The World Health Organization places chronic hepatitis B (CHB) among the top 10
causes of death worldwide [1], making this disease one of the most important
diagnoses a medical practitioner will face. There are estimated to be more ... Cited by 5 - Related articles - All 20 versions
XJ Zhou, J Ke, WM Sallas, C Farrell, DL … - The Journal of Clinical Pharmacology, 2009 - jclinpharm.highwire.org Telbivudine is a new nucleoside analog indicated for the treatment of chronic
hepatitis B infection. A population pharmacokinetic model was developed based on
data pooled from 16 early phase studies in 363 healthy participants and ... Related articles - All 5 versions
SJ Hadziyannis, D Vassilopoulos - Expert Review of Gastroenterology and Hepatology, 2008 - ingentaconnect.com Treatment of chronic hepatitis B with oral nucleos(t)ide analogs is evolving
rapidly with newer compounds gaining approval. Recently, the US FDA and European
Medicines Agency (EMEA) have approved telbivudine, a potent anti-hepatitis ... Related articles - BL Direct - All 4 versions
이관식 - Korean Journal of Hepatology, 2007 - kaim.or.kr Page 1. The Korean Journal of Hepatology 2007 ; 13 : 447 - 488 DOI: 10.3350/kjhep.
2007.13.4.447 - 447 - <대한간학회 가이드라인(KASL Guidelines)> ... Related articles - View as HTML - All 8 versions
RM Verdugo, AM Berenguer, MVG Navarro, ES … - Farmacia Hospitalaria, 2008 - sefh.es Palabras clave: Hepatitis B. Interferón alfa 2b. Interferón pegilado alfa 2a.
Lamivudina. Adefovir. Entecavir. Telbivudina. Guías de práctica clínica. ...
Objective: To define the role of those drugs available for hepatitis B ... Related articles - View as HTML - All 6 versions
